Poplar Healthcare Management, LLC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Poplar Healthcare Management, LLC - overview
Location
Memphis, TN, US
Primary Industry
Healthcare
About
Poplar Healthcare Management, LLC specializes in providing innovative healthcare management solutions, focused on improving the efficiency and effectiveness of diagnostic services within the healthcare sector. Poplar Healthcare Management, LLC operates in the healthcare industry, providing diagnostic testing services. The company was acquired by PathAI, Inc. on July 26, 2021, a move aimed at enhancing PathAI's capabilities in clinical diagnostics.
The firm is headquartered in Memphis, US. The company’s core offerings revolve around advanced healthcare management solutions that address specific needs in the market. These innovative services include diagnostic testing and related healthcare solutions designed to enhance operational efficiency. The clientele primarily encompasses healthcare providers, hospitals, and laboratories across North America, Europe, and parts of Asia, ensuring a diverse customer base benefiting from the company’s tailored services.
Poplar Healthcare Management, LLC generates revenue through various channels, including service agreements and direct sales of diagnostic testing solutions. Their pricing structure involves service packages that cater to various client needs, fostering long-term partnerships and recurring revenue streams through multi-year agreements. Following its acquisition by PathAI, Inc. in July 2021, Poplar Healthcare Management aims to enhance its product offerings by integrating its services with PathAI's artificial intelligence-powered pathology platform.
The company plans to expand its market presence across additional states in the U. S. , with a focus on optimizing its testing services to better serve healthcare providers. Recent funding will support the integration of their diagnostic services into PathAI's platform, ultimately improving their service delivery and increasing the value proposition to clients.
Current Investors
Bristol-Myers Squibb Company, Laboratory Corporation of America Holdings, PathAI, Inc.
Primary Industry
Healthcare
Sub Industries
Molecular Science, Genetics & Gene Therapy, Bioinformatics, Diagnostic, Medical & Imaging Laboratories
Website
www.poplarhealthcare.com
Company Stage
Add-on
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.